BioHarvest Sciences Inc. Common Stock
NASDAQ:BHSTAgricultural Inputs
+$0.08 today
- Market cap
- $50.25M
- Beta
- 1.33
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$0.50
Volume 0.01M
Average 0.03M
BHST Pre-Tax Margin
Income before tax as a percentage of revenue.
BioHarvest Sciences Inc. Common StockNASDAQ: BHST
Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026
Pre-tax margin narrows to -30.5%
Pre-tax margin was -30.5% in Q1 FY2026, down 1.2 pp from a year earlier. On a trailing-twelve-month basis it was -32.3%, down 1.2 pp year over year. Over 3 fiscal years it widened by 172.3 pp.
Context
- Pre-tax margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Pre-Tax Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -32.0%
- Year-over-year change
- +19.2pp
| Period | Period end | Pre-Tax Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -32.0% | +19.2pp |
| FY2024 | 2024-12-31 | -51.2% | +47.9pp |
| FY2023 | 2023-12-31 | -99.1% | +105.2pp |
| FY2022 | 2022-12-31 | -204.4% | +263.1pp |
| FY2021 | 2021-12-31 | -467.5% | — |
Pre-Tax Margin vs competitors
How BHST compares with its peers on the latest reported figures
- BHST's LTM Mar 2026 pre-tax margin of -32.3% is the 7th highest of the 8 companies compared; the peer median is -7.1%.
- Its year-over-year change of -1.2 pp is the 5th highest of 8, against a peer median of -0.8 pp.
- Over three fiscal years its change of +172.3 pp compares with a peer median of -12.0 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM May 2025 | 24.5% | +4.8 pp | +37.6 pp | |
| LTM Mar 2026 | 4.6% | -0.8 pp | +1.5 pp | |
| LTM Mar 2026 | 4.1% | +2.3 pp | -1.1 pp | |
| LTM Mar 2026 | -7.1% | -4.3 pp | -12.0 pp | |
| LTM Mar 2026 | -8.3% | +16.7 pp | -15.1 pp | |
| LTM Mar 2026 | -28.1% | -23.8 pp | -42.5 pp | |
| LTM Mar 2026 | -32.3% | -1.2 pp | +172.3 pp | |
| LTM Mar 2026 | -47.4% | -43.9 pp | -54.9 pp | |
USGOU.S. GoldMining Inc. | FY2025 | — | — | — |
| Peer median (excluding BHST) | -7.1% | -0.8 pp | -12.0 pp | |
Competitors are the stored peer set for BHST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.1M | 5.5M | 12.67M | 25.19M | 34.51M |
| Cost of Revenue | 1.43M | 4.28M | 7.04M | 11.25M | 14.03M |
| Gross Profit | 670K | 1.22M | 5.63M | 13.94M | 20.48M |
| Gross Margin | 31.9% | 22.2% | 44.5% | 55.4% | 59.3% |
| Research & Development | 4.13M | 2.31M | 3.37M | 4.8M | 5.31M |
| Selling, General & Admin | 4.76M | 9.35M | 12.08M | 14.67M | 19.14M |
| Operating Expenses | 9.16M | 11.83M | 15.6M | 20.93M | 26.05M |
| Depreciation & Amortization | 385.58K | 712K | 840K | 1.25M | 1.62M |
| EBITDA | (8.64M) | (9.13M) | (9.76M) | (9.72M) | (6.71M) |
| EBITDA Margin | -410.9% | -166.0% | -77.0% | -38.6% | -19.5% |
| Operating Income | (8.49M) | (10.61M) | (9.97M) | (6.99M) | (5.58M) |
| Operating Margin | -403.9% | -193.0% | -78.6% | -27.7% | -16.2% |
| Interest Income | 0 | 0 | 0 | 0 | 54K |
| Interest Expense | 805K | 1.4M | 1.96M | 1.93M | 2.72M |
| Other Income / Expenses | (1.34M) | (624K) | (2.6M) | (5.92M) | (5.48M) |
| Income Before Tax | (9.83M) | (11.24M) | (12.56M) | (12.91M) | (11.06M) |
| Pre-Tax Margin | -467.5% | -204.4% | -99.1% | -51.2% | -32.0% |
| Income Tax Expense | 0 | 0 | 0 | 8K | 76K |
| Net Income | (9.83M) | (11.24M) | (12.56M) | (12.91M) | (11.14M) |
| Net Margin | -467.5% | -204.4% | -99.1% | -51.3% | -32.3% |
| EPS (Basic) | (0.70) | (0.70) | (0.93) | (0.80) | (0.60) |
| EPS (Diluted) | (0.70) | (0.70) | (0.93) | (0.80) | (0.60) |
| Weighted Avg Shares | 12.45M | 13.05M | 13.53M | 16.19M | 18.41M |
| Weighted Avg Shares (Diluted) | 12.45M | 13.05M | 13.53M | 16.19M | 18.41M |
BioHarvest Sciences Inc. Common Stock
NASDAQ:BHST
Intrinsic Alpha fair value
Locked
Current Price
$2.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.